首页 | 本学科首页   官方微博 | 高级检索  
     

舒喘灵雾化吸入佐治支气管肺炎患儿疗效研究
引用本文:肖水生,张冰冰. 舒喘灵雾化吸入佐治支气管肺炎患儿疗效研究[J]. 实用心脑肺血管病杂志, 2011, 19(12): 2021-2022
作者姓名:肖水生  张冰冰
作者单位:顺德区顺德聚龙医院内科,广东省佛山市,528319
摘    要:目的观察舒喘灵辅助雾化吸入治疗支气管肺炎患儿的临床效果,并关注治疗前、后血清中白细胞介素12(IL-12)水平的差别,以期为临床工作提供指导。方法收集在我院确诊为支气管肺炎的患儿共138例,按患儿的入院顺序分为两组,观察组69例,在常规抗炎治疗的基础上加用舒喘灵雾化吸入;对照组69例,应用常规治疗。应用酶联免疫吸附实验于治疗前、治疗7d后检测患儿血清中IL-12的表达。结果观察组患儿啰音消失时间、住院时间明显短于对照组,观察组患儿的治愈率明显高于对照组。观察组与对照组患儿治疗7d后血清中IL-12的含量均下降,但是观察组患儿的血清中IL-12的下降值明显高于对照组。结论对支气管肺炎患儿在常规治疗基础上加用舒喘灵辅助雾化吸入治疗,临床效果好,并能有效下调患儿血清中IL-12的表达,进而抑制由IL-12引发的微环境中的炎性级联反应,临床治疗效果好。

关 键 词:支气管肺炎  吸入  白细胞介素12

The Efficacy Observation by Salbutamol of Aerosol Inhalation in Children with Bronchopneumonia
XIAO Shui-sheng,ZHANG Bing-bing. The Efficacy Observation by Salbutamol of Aerosol Inhalation in Children with Bronchopneumonia[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2011, 19(12): 2021-2022
Authors:XIAO Shui-sheng  ZHANG Bing-bing
Affiliation:XIAO Shui-sheng,ZHANG Bing-bing.Department of Internal,Julong Hespital of Shunde Distria,Foshan 528319,China
Abstract:Objective To observe the curative effect,IL-12 change by salbutamol of aerosol inhalation in children with bronchopneumonia,for accumulating the clinical experience,directing the clinical work.Methods 138 children with bronchopneumonia were divided into two groups.The control group(69 cases) were treated by routine treatment,the observation group(69 cases) were added salbutamol of aerosol inhalation treatment.Observated their efficacy and the change of IL-12 after treatment in the two groups.Results The cli...
Keywords:Bronchopneumonia  Inhalation  IL-12  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号